{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:07:05Z","timestamp":1784304425568,"version":"3.55.0"},"reference-count":183,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>COVID-19 and seasonal influenza have taken a huge toll on the global economy and global health. Given the potential of COVID-19 to transform into a chronic epidemic akin to seasonal influenza, the influenza virus and SARS-CoV-2 will continue to be a significant threat to healthcare for some time to come. Coinfection involving the two viruses has been proven to worsen the severity of the illness, as evidenced by clinical observational data. Vaccination remains the most effective measure in the prevention and treatment of infectious diseases. In addition, the coadministration of influenza virus and SARS-CoV-2 vaccines offered greater benefits than either vaccine alone. Combination vaccines are also a major hotspot in novel vaccine development. This review highlights the advancements in the development of combined vaccines for COVID-19 and seasonal influenza, as demonstrated in animal studies and clinical trials, and emphasizes the importance of a combined vaccine.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1578733","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T06:16:54Z","timestamp":1750832214000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Progress in combination vaccines and the co-administration of influenza virus and SARS-CoV-2 vaccines"],"prefix":"10.3389","volume":"16","author":[{"given":"Chengyu","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenguang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiannan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiecheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2117692","article-title":"Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza","author":"Stepanova","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"B2","unstructured":"Influenza (seasonal)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1750-2659.2009.00073.x","article-title":"Estimates of US influenza-associated deaths made using four different methods","author":"Thompson","year":"2009","journal-title":"Influenza Other Respir Viruses"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3201\/eid2608.201229","article-title":"Decreased influenza incidence under COVID-19 control measures, Singapore","author":"Soo","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1038\/s41467-021-23440-1","article-title":"Impact of COVID-19 outbreaks and interventions on influenza in China and the United States","author":"Feng","year":"2021","journal-title":"Nat Commun"},{"key":"B6","volume-title":"FluNet summary","year":"2024"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-2667(20)30090-6","article-title":"Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study","author":"Cowling","year":"2020","journal-title":"Lancet Public Health"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.14661","article-title":"Influenza in the COVID-19 era","author":"Solomon","year":"2020","journal-title":"Jama"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab607","article-title":"Estimating the impact of low influenza activity in 2020 on population immunity and future influenza seasons in the United States","volume":"9","author":"Lee","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29751","article-title":"Resurgence of seasonal influenza driven by A\/H3N2 and B\/Victoria in succession during the 2023\u20132024 season in Beijing showing increased population susceptibility","author":"Zhu","year":"2024","journal-title":"J Med Virol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26990","article-title":"A brief review of influenza virus infection","author":"Javanian","year":"2021","journal-title":"J Med Virol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105505","article-title":"The race toward a universal influenza vaccine: Front runners and the future directions","author":"Hu","year":"2023","journal-title":"Antiviral Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.1124513","article-title":"Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus","author":"Stevens","year":"2006","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1093\/infdis\/jiy696","article-title":"Immunodominance and antigenic variation of influenza virus hemagglutinin: implications for design of universal vaccine immunogens","volume":"219","author":"Zost","year":"2019","journal-title":"J Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2017.0141","article-title":"Influenza virus: dealing with a drifting and shifting pathogen","author":"Kim","year":"2018","journal-title":"Viral Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies","author":"Belongia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.chom.2018.06.016","article-title":"Overcoming barriers in the path to a universal influenza virus vaccine","author":"Coughlan","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-120617-041310","article-title":"Is a universal influenza virus vaccine possible","author":"Nachbagauer","year":"2020","journal-title":"Annu Rev Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy103","article-title":"A universal influenza vaccine: the strategic plan for the national institute of allergy and infectious diseases","author":"Erbelding","year":"2018","journal-title":"J Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","author":"Throsby","year":"2008","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","author":"Zebedee","year":"1988","journal-title":"J Virol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4110\/in.2015.15.5.213","article-title":"Mechanisms of cross-protection by influenza virus M2-based vaccines","author":"Lee","year":"2015","journal-title":"Immune Netw"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.74.15.6800-6807.2000","article-title":"Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes","author":"Voeten","year":"2000","journal-title":"J Virol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2009.16","article-title":"Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes","author":"Brown","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an independent correlate of protection","author":"Monto","year":"2015","journal-title":"J Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/v6062465","article-title":"In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen","author":"Wohlbold","year":"2014","journal-title":"Viruses"},{"key":"B28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/v14081684","article-title":"Progress towards the development of a universal influenza vaccine","volume":"14","author":"Wang","year":"2022","journal-title":"Viruses"},{"key":"B29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/vaccines9070793","article-title":"Next generation of computationally optimized broadly reactive HA vaccines elicited cross-reactive immune responses and provided protection against H1N1 virus infection","volume":"9","author":"Huang","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1038\/s41598-020-79590-7","article-title":"Next generation methodology for updating HA vaccines against emerging human seasonal influenza A(H3N2) viruses","author":"Allen","year":"2021","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2012.246","article-title":"Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus","author":"Kim","year":"2013","journal-title":"Mol Ther"},{"key":"B32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/vaccines8020197","article-title":"Construction and immunogenicity of a novel multivalent vaccine prototype based on conserved influenza virus antigens","volume":"8","author":"Kirsteina","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0305-x","article-title":"Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses","author":"Kanekiyo","year":"2019","journal-title":"Nat Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201901176","article-title":"Double-layered M2e-NA protein nanoparticle immunization induces broad cross-protection against different influenza viruses in mice","author":"Wang","year":"2020","journal-title":"Adv Healthc Mater"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151922","article-title":"Entrapment of H1N1 influenza virus derived conserved peptides in PLGA nanoparticles enhances T cell response and vaccine efficacy in pigs","author":"Hiremath","year":"2016","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12350","article-title":"Adenoviral vectors as novel vaccines for influenza","author":"Coughlan","year":"2015","journal-title":"J Pharm Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.07.095","article-title":"Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice","author":"Asthagiri Arunkumar","year":"2019","journal-title":"Vaccine"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.09.086","article-title":"Broad cross-protective anti-hemagglutination responses elicited by influenza microconsensus DNA vaccine","volume":"36","author":"Yan","year":"2018","journal-title":"Vaccine"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.04.018","article-title":"A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice","author":"Freyn","year":"2020","journal-title":"Mol Ther"},{"key":"B40","unstructured":"WHO coronavirus (COVID-19) dashboard"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/s12961-023-00963-1","article-title":"Limitations of COVID-19 testing and case data for evidence-informed health policy and practice","author":"Alvarez","year":"2023","journal-title":"Health Res Policy Syst"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3026","article-title":"Management of post-acute covid-19 in primary care","volume":"370","author":"Greenhalgh","year":"2020","journal-title":"Bmj"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","author":"Nalbandian","year":"2021","journal-title":"Nat Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/01410768231154703","article-title":"Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study","author":"Dennis","year":"2023","journal-title":"J R Soc Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.3390\/ijerph19137926","article-title":"Knowledge, attitude, and perception of cancer patients towards COVID-19 in Pakistan: A cross-sectional study","volume":"19","author":"Khattak","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B46","unstructured":"The situation of the coronavirus infection in China\n          \n          \n          2023"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2022.08.001","article-title":"Clinical features and outcomes of hospitalized patients with COVID-19 during the Omicron wave in Shanghai, China","author":"Wang","year":"2023","journal-title":"J Infect"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1039123","article-title":"As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it","author":"Xu","year":"2022","journal-title":"Front Public Health"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","author":"Chan","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.02.071","article-title":"Structure analysis of the receptor binding of 2019-nCoV","author":"Chen","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","author":"Tai","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.47836","article-title":"Advances and challenges in the prevention and treatment of COVID-19","author":"Han","year":"2020","journal-title":"Int J Med Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","author":"Fehr","year":"2015","journal-title":"Methods Mol Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","author":"Tregoning","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109126","article-title":"Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities","author":"Hayn","year":"2021","journal-title":"Cell Rep"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.058","article-title":"Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy","author":"Benvenuto","year":"2020","journal-title":"J Infect"},{"key":"B59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41420-021-00428-w","article-title":"SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes","author":"Ferreira","year":"2021","journal-title":"Cell Death Discov"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates","author":"Corbett","year":"2020","journal-title":"N Engl J Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1126\/scitranslmed.abi4547","article-title":"Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates","volume":"13","author":"Francica","year":"2021","journal-title":"Sci Transl Med"},{"key":"B62","unstructured":"COVID-19 vaccine tracker and landscape"},{"key":"B63","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41392-021-00797-9","article-title":"Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00253-021-11713-0","article-title":"Current view on novel vaccine technologies to combat human infectious diseases","author":"Mati\u0107","year":"2022","journal-title":"Appl Microbiol Biotechnol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01370-1","article-title":"Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19","author":"Ward","year":"2021","journal-title":"Nat Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3390\/vaccines9121409","article-title":"VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants","volume":"9","author":"Prates-Syed","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.08.053","article-title":"Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice","author":"Ren","year":"2018","journal-title":"Vaccine"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2017.12.020","article-title":"Intramuscular and intranasal immunization with an H7N9 influenza virus-like particle vaccine protects mice against lethal influenza virus challenge","author":"Ren","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.virusres.2015.01.007","article-title":"H5N1 influenza virus-like particle vaccine protects mice from heterologous virus challenge better than whole inactivated virus","author":"Ren","year":"2015","journal-title":"Virus Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41467-020-20653-8","article-title":"SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice","author":"Tian","year":"2021","journal-title":"Nat Commun"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.2174\/1566523218666180607091311","article-title":"Inhibition of West Nile virus Replication by Bifunctional siRNA Targeting the NS2A and NS5 Conserved Region","author":"Karothia","year":"2018","journal-title":"Curr Gene Ther"},{"key":"B72","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA vaccine development","author":"Fang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B73","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/pharmaceutics12010030","article-title":"Engineered nanodelivery systems to improve DNA vaccine technologies","volume":"12","author":"Lim","year":"2020","journal-title":"Pharmaceutics"},{"key":"B74","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-coV-2 entry by using human ACE2","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/440435a","article-title":"Avian flu: influenza virus receptors in the human airway","author":"Shinya","year":"2006","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2012.00414.x","article-title":"Influenza A H1N1 induces declines in alveolar gas exchange in mice consistent with rapid post-infection progression from acute lung injury to ARDS","author":"Traylor","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"B77","first-page":"68","article-title":"Potential problem of the co-occurrence of pandemic COVID-19 and seasonal influenza","volume":"70","author":"Mezencev","year":"2021","journal-title":"Epidemiol Mikrobiol Imunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2022.100306","article-title":"Co-existence and co-infection of influenza A viruses and coronaviruses: Public health challenges","author":"Yang","year":"2022","journal-title":"Innovation (Camb)"},{"key":"B79","unstructured":"confirmed cases of influenza\n          \n          \n          2024"},{"key":"B80","unstructured":"Number of COVID-19 cases reported to WHO\n          \n          \n          2024"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1810","article-title":"Coinfection, severe acute respiratory syndrome coronavirus 2 (SARS-coV-2), and influenza: an evolving puzzle","author":"Covin","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26364","article-title":"High prevalence of SARS-CoV-2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran","author":"Hashemi","year":"2021","journal-title":"J Med Virol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3201\/eid2606.200299","article-title":"Co-infection with SARS-coV-2 and influenza A virus in patient with pneumonia, China","author":"Wu","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-020-03519-3","article-title":"How COVID-19 is changing the cold and flu season","author":"Jones","year":"2020","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01161-24","article-title":"Epidemiology of respiratory pathogens in patients with acute respiratory infections during the COVID-19 pandemic and after easing of COVID-19 restrictions","author":"Zhao","year":"2024","journal-title":"Microbiol Spectr"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29929","article-title":"Analyzing infections caused by 11 respiratory pathogens in children: Pre- and post-COVID-19 pandemic trends in China","author":"Li","year":"2024","journal-title":"J Med Virol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41422-021-00473-1","article-title":"Coinfection with influenza A virus enhances SARS-CoV-2 infectivity","author":"Bai","year":"2021","journal-title":"Cell Res"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3720","article-title":"Covid-19: Risk of death more than doubled in people who also had flu, English data show","volume":"370","author":"Iacobucci","year":"2020","journal-title":"Bmj"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyab081","article-title":"Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design","author":"Stowe","year":"2021","journal-title":"Int J Epidemiol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-021-2317-2","article-title":"Co-infection of SARS-COV-2 and influenza A virus: A case series and fast review","author":"Xiang","year":"2021","journal-title":"Curr Med Sci"},{"key":"B91","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-021-00618-z","article-title":"Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza","author":"Bao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01791-21","article-title":"SARS-coV-2 and influenza A virus coinfections in ferrets","author":"Huang","year":"2022","journal-title":"J Virol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01873-21","article-title":"Coinfection with SARS-coV-2 and influenza A virus increases disease severity and impairs neutralizing antibody and CD4(+) T cell responses","author":"Kim","year":"2022","journal-title":"J Virol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: a systematic review and meta-analysis","author":"Lansbury","year":"2020","journal-title":"J Infect"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcvp.2021.100036","article-title":"Co-infection of SARS-CoV-2 and influenza viruses: A systematic review and meta-analysis","author":"Dao","year":"2021","journal-title":"J Clin Virol Plus"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26740","article-title":"Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses","author":"Sarkar","year":"2021","journal-title":"J Med Virol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.12.05040","article-title":"The role of respiratory co-infection with influenza or respiratory syncytial virus in the clinical severity of COVID-19 patients: A systematic review and meta-analysis","author":"Cong","year":"2022","journal-title":"J Glob Health"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2365","article-title":"Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis","author":"Krumbein","year":"2023","journal-title":"Rev Med Virol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251170","article-title":"Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis","author":"Musuuza","year":"2021","journal-title":"PloS One"},{"key":"B100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijid.2023.08.021","article-title":"Prevalence and associated outcomes of coinfection between SARS-CoV-2 and influenza: a systematic review and meta-analysis","author":"Yan","year":"2023","journal-title":"Int J Infect Dis"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.773130","article-title":"Impact of coinfection with SARS-coV-2 and influenza on disease severity: A systematic review and meta-analysis","author":"Guan","year":"2021","journal-title":"Front Public Health"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)00383-x","article-title":"SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses","author":"Swets","year":"2022","journal-title":"Lancet"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3201\/eid2802.211727","article-title":"Viral interference between respiratory viruses","author":"Piret","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6173","article-title":"Seasonal influenza activity during the SARS-coV-2 outbreak in Japan","author":"Sakamoto","year":"2020","journal-title":"Jama"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255541","article-title":"Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients","author":"Taghioff","year":"2021","journal-title":"PloS One"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000002427","article-title":"Association between influenza vaccination and SARS-CoV-2 infection and its outcomes: systematic review and meta-analysis","author":"Jiang","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"B107","doi-asserted-by":"publisher","first-page":"7870","DOI":"10.3390\/ijerph17217870","article-title":"The association between influenza vaccination and the risk of SARS-coV-2 infection, severe illness, and death: A systematic review of the literature","volume":"17","author":"Del Riccio","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3201\/eid2810.221134","article-title":"Effectiveness of Booster and Influenza Vaccines against COVID-19 among Healthcare Workers, Taiwan","author":"Sim","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.02.013","article-title":"Effect of the 2020\/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers","author":"Domnich","year":"2022","journal-title":"Vaccine"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2022.12.016","article-title":"Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar","author":"Tayar","year":"2023","journal-title":"J Infect Public Health"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000028479","article-title":"Does influenza vaccination help reduce incidence of COVID-19 infection among hospital employees","author":"Shosha","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106351","article-title":"Vaccination against seasonal influenza and socio-economic and environmental factors as determinants of the geographic variation of COVID-19 incidence and mortality in the Italian elderly","author":"Cocco","year":"2021","journal-title":"Prev Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1852010","article-title":"The association of previous influenza vaccination and coronavirus disease-2019","author":"Green","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.33730","article-title":"Association of influenza vaccination with SARS-coV-2 infection and associated hospitalization and mortality among patients aged 66 years or older","author":"Hosseini-Moghaddam","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.10.021","article-title":"Effect of inactivated influenza vaccination on human coronavirus infection: Secondary analysis of a randomized trial in Hutterite colonies","author":"Chen","year":"2021","journal-title":"Vaccine"},{"key":"B116","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ajic.2021.02.012","article-title":"Impact of the influenza vaccine on COVID-19 infection rates and severity","author":"Conlon","year":"2021","journal-title":"Am J Infect Control"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02702-2","article-title":"Effect of influenza vaccine on COVID-19 mortality: a retrospective study","author":"Candelli","year":"2021","journal-title":"Intern Emerg Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2021.04.006","article-title":"Association between Influenza Vaccination and severe COVID-19 outcomes at a designated COVID-only hospital in Brooklyn","author":"Umasabor-Bubu","year":"2021","journal-title":"Am J Infect Control"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab594","article-title":"Sequential delivery of live attenuated influenza vaccine and severe acute respiratory syndrome coronavirus 2 (SARS-coV-2) in the ferret model can reduce SARS-coV-2 shedding and does not result in enhanced lung pathology","author":"Ryan","year":"2022","journal-title":"J Infect Dis"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009928","article-title":"Induction of trained immunity by influenza vaccination - impact on COVID-19","author":"Debisarun","year":"2021","journal-title":"PloS Pathog"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01373","article-title":"Activation of TLR7 and innate immunity as an efficient method against COVID-19 pandemic: imiquimod as a potential therapy","author":"Poulas","year":"2020","journal-title":"Front Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-100001","article-title":"Control of human viral infections by natural killer cells","author":"Jost","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0316-1","article-title":"The activation of bystander CD8(+) T cells and their roles in viral infection","author":"Kim","year":"2019","journal-title":"Exp Mol Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01692","article-title":"The potential effect of novel coronavirus SARS-coV-2 on NK cells; A perspective on potential therapeutic interventions","author":"Jewett","year":"2020","journal-title":"Front Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab - a big effect: nonspecific immunomodulation by vaccines","author":"Benn","year":"2013","journal-title":"Trends Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu079","article-title":"Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children","author":"Cao","year":"2014","journal-title":"J Infect Dis"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106717","article-title":"Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses","author":"Gupta","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B128","unstructured":"Coadministration of seasonal inactivated influenza and COVID-19 vaccines: interim guidance"},{"key":"B129","unstructured":"COVID-19 - SARS-coV-2"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.12.043","article-title":"Association of dual COVID-19 and seasonal influenza vaccination with COVID-19 infection and disease severity","author":"Xie","year":"2023","journal-title":"Vaccine"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.19191\/ep22.5-6.070","article-title":"First SARS-CoV-2 vaccine booster and influenza vaccination: risk assessment of COVID-19 hospitalisation and death","author":"Russo","year":"2022","journal-title":"Epidemiol Prev"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(21)00409-4","article-title":"Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial","author":"Toback","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.07.021","article-title":"Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: A randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China","author":"Shenyu","year":"2022","journal-title":"Vaccine"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)02329-1","article-title":"Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial","author":"Lazarus","year":"2021","journal-title":"Lancet"},{"key":"B135","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/s2213-2600(21)00557-9","article-title":"Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged \u226565 years: a phase 2, randomised, open-label study","author":"Izikson","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.07.033","article-title":"Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial","author":"Chen","year":"2022","journal-title":"Vaccine"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.43166","article-title":"Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical Trial","author":"Walter","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.03.061","article-title":"Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial","author":"Baum","year":"2024","journal-title":"Vaccine"},{"key":"B139","year":""},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.103016","article-title":"Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trial","author":"Tapia-Calle","year":"2025","journal-title":"EClinicalMedicine"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01578-21","article-title":"A single vaccine protects against SARS-coV-2 and influenza virus in mice","author":"Cao","year":"2022","journal-title":"J Virol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41541-024-00857-5","article-title":"An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza","author":"Xing","year":"2024","journal-title":"NPJ Vaccines"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01337-22","article-title":"A recombinant VSV-based bivalent vaccine effectively protects against both SARS-coV-2 and influenza A virus infection","author":"Ao","year":"2022","journal-title":"J Virol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/14760584.2020.1711056","article-title":"Insights into current clinical research on the immunogenicity of live attenuated influenza vaccines","author":"Isakova-Sivak","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"B145","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/vaccines8020196","article-title":"Recombinant live attenuated influenza vaccine viruses carrying conserved T-cell epitopes of human adenoviruses induce functional cytotoxic T-cell responses and protect mice against both infections","volume":"8","author":"Isakova-Sivak","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104864","article-title":"Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses","author":"Matyushenko","year":"2020","journal-title":"Antiviral Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1394842","article-title":"Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane","author":"Vitelli","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.73.5.3723-3732.1999","article-title":"Attenuated vesicular stomatitis viruses as vaccine vectors","author":"Roberts","year":"1999","journal-title":"J Virol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/vaccines11061063","article-title":"Intranasal single-replication influenza vector induces cross-reactive serum and mucosal antibodies against SARS-coV-2 variants","volume":"11","author":"Moser","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.03.040","article-title":"Mucosal immunization with dual influenza\/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge","author":"Hill-Batorski","year":"2024","journal-title":"Vaccine"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.3390\/vaccines11091404","article-title":"Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses","volume":"11","author":"Ouyang","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B152","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3390\/vaccines10060944","article-title":"Influenza virus-like particle-based hybrid vaccine containing RBD induces immunity against influenza and SARS-coV-2 viruses","volume":"10","author":"Bommireddy","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126463","article-title":"SARS-CoV-2 spike-based virus-like particles incorporate influenza H1\/N1 antigens and induce dual immunity in mice","author":"Sanchez-Martinez","year":"2024","journal-title":"Vaccine"},{"key":"B154","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41541-022-00478-w","article-title":"Rational development of a combined mRNA vaccine against COVID-19 and influenza","author":"Ye","year":"2022","journal-title":"NPJ Vaccines"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00668-24","article-title":"A decavalent composite mRNA vaccine against both influenza and COVID-19","author":"Wang","year":"2024","journal-title":"mBio"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012508","article-title":"A chimeric mRNA vaccine of S-RBD with HA conferring broad protection against influenza and COVID-19 variants","author":"Hao","year":"2024","journal-title":"PloS Pathog"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.05.442782","article-title":"Combination respiratory vaccine containing recombinant SARS-coV-2 spike and quadrivalent seasonal influenza hemagglutinin nanoparticles with matrix-M adjuvant","author":"Massare","year":"2021","journal-title":"bioRxiv"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104297","article-title":"A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core","author":"Shi","year":"2022","journal-title":"EBioMedicine"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2231573","article-title":"Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD","author":"Li","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.12.084","article-title":"Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection","author":"Huang","year":"2024","journal-title":"Vaccine"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29479","article-title":"A subunit-based influenza\/SARS-CoV-2 Omicron combined vaccine induced potent protective immunity in BALB\/c mice","author":"Zhang","year":"2024","journal-title":"J Med Virol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1473428","article-title":"A multi-antigen vaccinia vaccine broadly protected mice against SARS-CoV-2 and influenza A virus while also targeting SARS-CoV-1 and MERS-CoV","author":"Gao","year":"2024","journal-title":"Front Immunol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.1038\/s41598-024-54421-1","article-title":"Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19\/influenza vaccine","author":"Handabile","year":"2024","journal-title":"Sci Rep"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(22)00131-x","article-title":"Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials","author":"Zhu","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B165","unstructured":"NanoFlu\/NVX CoV 2373 combination vaccine - Novavax"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1111\/phn.13561","article-title":"Attitudes of the population toward vaccines during the COVID-19 pandemic: the PROACTIVE study","author":"Calzolari","year":"2025","journal-title":"Public Health Nurs"},{"key":"B167","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/idr17020018","article-title":"Utilizing an educational intervention to enhance influenza vaccine literacy and acceptance among minoritized adults in southern californian vulnerable communities in the post-COVID-19 era","volume":"17","author":"Abdul-Mutakabbir","year":"2025","journal-title":"Infect Dis Rep"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1186\/s12889-025-22496-8","article-title":"Exploring influenza vaccination determinants through digital participatory surveillance","author":"Kelley","year":"2025","journal-title":"BMC Public Health"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2025.102693","article-title":"A questionnaire survey for Japanese parents on intention to vaccinate their children against COVID-19 and influenza","author":"Kitano","year":"2025","journal-title":"J Infect Chemother"},{"key":"B170","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1017\/dmp.2025.55","article-title":"Understanding vaccine hesitancy at montefiore medical center: implications for public health preparedness","author":"Shapiro","year":"2025","journal-title":"Disaster Med Public Health Prep"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127057","article-title":"Pharmacy and healthcare provider offices as convenient adult vaccination settings in the US: Patient experiences from a survey of recently-vaccinated adults","author":"La","year":"2025","journal-title":"Vaccine"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2025.2462412","article-title":"US consumer and healthcare professional preferences for combination COVID-19 and influenza vaccines","author":"Poulos","year":"2025","journal-title":"J Med Econ"},{"key":"B173","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13063-023-07862-4","article-title":"Delivering COVID-19 vaccine trials at speed: the implementation of a phase IV UK multi-centre randomised controlled trial to determine safety and immunogenicity of COVID-19 vaccines co-administered with seasonal influenza vaccines (ComFluCOV)","author":"Baos","year":"2024","journal-title":"Trials"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2022.109491","article-title":"An influenza virus vector candidate vaccine stably expressing SARS-CoV-2 receptor-binding domain produces high and long-lasting neutralizing antibodies in mice","author":"Zhao","year":"2022","journal-title":"Vet Microbiol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3390\/vaccines10071142","article-title":"Development of a T cell-based COVID-19 vaccine using a live attenuated influenza vaccine viral vector","volume":"10","author":"Isakova-Sivak","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00689-22","article-title":"A virion-based combination vaccine protects against influenza and SARS-coV-2 disease in mice","author":"Chaparian","year":"2022","journal-title":"J Virol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.scib.2022.05.018","article-title":"A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2","author":"Chen","year":"2022","journal-title":"Sci Bull (Beijing)"},{"key":"B178","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1038\/s41467-023-39560-9","article-title":"Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters","author":"Zhang","year":"2023","journal-title":"Nat Commun"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo4100","article-title":"A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus","volume":"9","author":"Wang","year":"2023","journal-title":"Sci Adv"},{"key":"B180","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1038\/s41467-023-37697-1","article-title":"An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters","author":"Deng","year":"2023","journal-title":"Nat Commun"},{"key":"B181","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3390\/vaccines11091453","article-title":"Single-dose intranasal immunisation with novel chimeric H1N1 expressing the receptor-binding domain of SARS-coV-2 induces robust mucosal immunity, tissue-resident memory T cells, and heterologous protection in mice","volume":"11","author":"Wang","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3390\/vaccines12101099","article-title":"Safety and immunogenicity study of a bivalent vaccine for combined prophylaxis of COVID-19 and influenza in non-human primates","volume":"12","author":"Stepanova","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"B183","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12985-024-02350-w","article-title":"Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza","volume":"21","author":"Stepanova","year":"2024","journal-title":"Virol J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1578733\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T06:16:56Z","timestamp":1750832216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1578733\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":183,"alternative-id":["10.3389\/fimmu.2025.1578733"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1578733","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"article-number":"1578733"}}